Thank you IMG Oncologists
I am excited to serve in this role and look forward to continue improving diversity/visa advocacy within the Heme/Onc community. ❤️

Dr. Nina Niu Sanford Krishan Jethwa Ibrahim Halil SAHIN, MD Aparna Raj Parikh Jonathan Loree Manju George MVSc PhD Rectal Cancer Survivor
Noam VanderWalde Chris Cann, MD
Retweets of this #videoShorts much appreciated!!
#CRCTrialsChat

Yes, can be listed ERBB2 amplification in some NGS reports ‼️

✳️Also important to note ERBB2/HER2 mutations are different than amplifications ‼️
✳️Currently available agents are for amplification not mutation ❗️

Researchers led by Anwaar Saeed published results from the CAMILLA trial showing that combining cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer is a promising treatment, potentially expanding treatment options. go.upmc.com/2028MEzEL

Thank you for the opportunity to discuss the new journal, JCO Oncology Advances. The submission portal will open soon! 📢📅

✳️While concluding the #ColorectalCancerAwarenessMonth just received this amazing news !!

✳️Our paper on KRAS targeting for patients with CRC is now accepted for a publication in JCO Oncology Practice ‼️
✳️We discussed the recent progress and elaborated future therapeutic opportunities…

Thank to everyone who contributed to this work Emil Lou, MD, PhD, FACP Joanne Xiu philip a philip John Marshall Mohamed E. Salem, MD, FASCO Ibrahim Halil SAHIN, MD and to the rest who are not on X. 🙏

If you treat colorectal cancer #CRC or Endometrial Cancer #EC , you may find our paper interesting. Differential responses to immune checkpoint inhibitors are governed by diverse mismatch repair gene alterations - PubMed #colorectalcancerawarenessmonth pubmed.ncbi.nlm.nih.gov/38350001/

As an aspiring oncologist, I value raising awareness for all types of cancer. This month, we are happy to contribute to the development of colorectal cancer research. I thank my mentor, Ibrahim Halil SAHIN, MD , so much for giving me this opportunity.

✳️While concluding the #ColorectalCancerAwarenessMonth just received this amazing news !!

✳️Our paper on KRAS targeting for patients with CRC is now accepted for a publication in JCO Oncology Practice ‼️
✳️We discussed the recent progress and elaborated future therapeutic opportunities…

✳️Our third presentation for #ColorectalCancerAwarenessMonth is now out ‼️

✳️In this brief presentation, I discussed therapeutic nuances for BRAF-mutant CRC, including the classes of BRAF mutations and treatment approaches with specific BRAF classes ‼️

Here are some take home…